Baker & McKenzie has recruited a new co-head for its Australian life sciences practice.
Amanda Turnill was previously a partner in the Sydney office of DLA Piper. She specializes in advising pharmaceutical and biotechnology companies on drug development and commercialization. She also advises clients on product liability litigation.
At DLA Piper, Turnill served as sector leader of the firm’s Asia-Pacific life sciences practice and co-chair of the global life sciences team. She joined that firm in 2011 from Clayton Utz, where she was a partner for eight years and co-led the national pharmaceutical and medical devices team. She began her career in London with the former Lovells in 1992, becoming a partner at that firm in 2000.
Baker & McKenzie, which has operated in Australia since 1964, has 220 lawyers in Sydney, including about 60 partners. The firm employs about 4,000 lawyers in 72 offices worldwide.